These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Electrophysiologic effects of amiodarone in tachyarrhythmias. Liu PH, Lin CC, Ko GC, Wang DJ, Shieh SM, Sung PK. Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917 [No Abstract] [Full Text] [Related]
23. Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern. Milstein S, Sharma AD, Klein GJ. Am J Cardiol; 1986 May 01; 57(13):1097-100. PubMed ID: 3706161 [Abstract] [Full Text] [Related]
25. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes. Feld GK, Nademanee K, Weiss J, Stevenson W, Singh BN. J Am Coll Cardiol; 1984 May 01; 3(5):1298-307. PubMed ID: 6707383 [Abstract] [Full Text] [Related]
26. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome. Brugada P, Wellens HJ. Am J Cardiol; 1985 Nov 15; 56(13):863-6. PubMed ID: 4061328 [Abstract] [Full Text] [Related]
31. Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone. Gondo N, Kumagai K, Matsuo K, Annoura M, Moroe K, Arakawa K. Cardiology; 1994 May 15; 84(4-5):292-7. PubMed ID: 8187115 [Abstract] [Full Text] [Related]
32. Atrial and ventricular vulnerability in a patient with the Wolff-Parkinson-White syndrome. Peters RW, Gonzalez R, Scheinman MM. Pacing Clin Electrophysiol; 1981 Jan 15; 4(1):17-22. PubMed ID: 6171787 [Abstract] [Full Text] [Related]
35. Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings. Hu J, Yu J, Chen Q, Hu J, Huang Q, Xia Z, Xia Z, Ju Z, Yuan P, Fan S, Xiong Q, Zhu B, Huang L, You C, Bao H, Wu Y, Cheng X, Li J, Marian AJ, Hong K. J Am Heart Assoc; 2019 Jul 02; 8(13):e012511. PubMed ID: 31234695 [Abstract] [Full Text] [Related]
36. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome]. Mabo P, Kermarrec A, Gras D, Paillard F, Bédossa M, Daubert C. Arch Mal Coeur Vaiss; 1992 Oct 02; 85(10):1443-8. PubMed ID: 1297293 [Abstract] [Full Text] [Related]
37. Amiodarone in long term management of refractory cardiac tachyarrhythmias. Lubbe WF, Mercer CJ, Roche AH, Lowe JB. N Z Med J; 1981 Jan 28; 93(676):31-5. PubMed ID: 6940024 [Abstract] [Full Text] [Related]
40. Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome. Klein GJ, Yee R, Sharma AD. Circulation; 1984 Sep 28; 70(3):402-11. PubMed ID: 6744543 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]